Healthcare -
Biotechnology - NASDAQ - US
$ 17.06
-3.62 %
$ 1.17 B
Market Cap
-6.16
P/E
ARVN - SHORT-TERM DEBT
Short-term Debt ARVN - Arvinas, Inc.
1.8 M
LAST VALUE
-29.29%
2 YEAR CAGR
21.71%
5 YEAR CAGR
0.00%
10 YEAR CAGR